| Dr Samuel Aaron Goldlust, MD | |
|
92 2nd St, Hackensack, NJ 07601-2191 | |
| (551) 996-5266 | |
| (551) 996-0589 |
| Full Name | Dr Samuel Aaron Goldlust |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 19 Years |
| Location | 92 2nd St, Hackensack, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225221922 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 25MA08913300 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Lukes Hospital Of Kansas City | Kansas city, MO | Hospital |
| Saint Luke's South Hospital | Overland park, KS | Hospital |
| Saint Luke's East Hospital | Lees summit, MO | Hospital |
| Hackensack University Medical Center | Hackensack, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Lukes Physician Group Inc | 3577476894 | 1070 |
News Archive
The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over diclofenac/hyaluronic acid gel. Such an added benefit cannot be derived from the dossier, however, as the drug manufacturer did not submit any relevant data: it did not cite any studies that directly compared ingenol mebutate with diclofenac/hyaluronic acid gel, and the method chosen by the manufacturer for an indirect comparison was unsuitable.
"Scientists from the University of Melbourne, Australia, the United States and Malawi studying infections with malaria and HIV, have found a strong link between the two diseases, which affect millions of people around the world and are major scourges in sub-Saharan Africa.
New and unique products created from bacterial cellulose — from electronic paper to treatment for wounds — will highlight a one-day symposium at the 227th national meeting of the American Chemical Society, the world's largest scientific society.
A review of studies of babies born after in vitro maturation (IVM) fertility treatment has suggested that they are more likely to be born larger than normal and to have more difficult births requiring more obstetric interventions such as caesareans.
› Verified 5 days ago
| Entity Name | Saint Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20031111000818 |
News Archive
The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over diclofenac/hyaluronic acid gel. Such an added benefit cannot be derived from the dossier, however, as the drug manufacturer did not submit any relevant data: it did not cite any studies that directly compared ingenol mebutate with diclofenac/hyaluronic acid gel, and the method chosen by the manufacturer for an indirect comparison was unsuitable.
"Scientists from the University of Melbourne, Australia, the United States and Malawi studying infections with malaria and HIV, have found a strong link between the two diseases, which affect millions of people around the world and are major scourges in sub-Saharan Africa.
New and unique products created from bacterial cellulose — from electronic paper to treatment for wounds — will highlight a one-day symposium at the 227th national meeting of the American Chemical Society, the world's largest scientific society.
A review of studies of babies born after in vitro maturation (IVM) fertility treatment has suggested that they are more likely to be born larger than normal and to have more difficult births requiring more obstetric interventions such as caesareans.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samuel Aaron Goldlust, MD 92 2nd St, Hackensack, NJ 07601-2191 Ph: () - | Dr Samuel Aaron Goldlust, MD 92 2nd St, Hackensack, NJ 07601-2191 Ph: (551) 996-5266 |
News Archive
The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over diclofenac/hyaluronic acid gel. Such an added benefit cannot be derived from the dossier, however, as the drug manufacturer did not submit any relevant data: it did not cite any studies that directly compared ingenol mebutate with diclofenac/hyaluronic acid gel, and the method chosen by the manufacturer for an indirect comparison was unsuitable.
"Scientists from the University of Melbourne, Australia, the United States and Malawi studying infections with malaria and HIV, have found a strong link between the two diseases, which affect millions of people around the world and are major scourges in sub-Saharan Africa.
New and unique products created from bacterial cellulose — from electronic paper to treatment for wounds — will highlight a one-day symposium at the 227th national meeting of the American Chemical Society, the world's largest scientific society.
A review of studies of babies born after in vitro maturation (IVM) fertility treatment has suggested that they are more likely to be born larger than normal and to have more difficult births requiring more obstetric interventions such as caesareans.
› Verified 5 days ago
David Steinberg, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 940 Main St, Hackensack, NJ 07601 Phone: 201-487-2273 | |
Dr. Shani Stein, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 60 Second St, 1st Floor Hackensack University Medical Center, Hackensack, NJ 07601 Phone: 201-996-3440 Fax: 201-996-5995 | |
Dr. Harshasu Barot, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 30 Prospect Ave, Hackensack, NJ 07601 Phone: 844-464-9355 | |
Alberto Mario Goldwaser, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 24 Bergen St, Hackensack, NJ 07601 Phone: 201-342-3500 Fax: 201-342-1900 | |
Dr. Samuel Singer, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 92 2nd St, Hackensack, NJ 07601 Phone: 551-996-5266 Fax: 551-996-0589 | |
Dr. Kaitlin Johanna Reilly-kit, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 360 Essex St., Suite 303, Hackensack, NJ 07601 Phone: 551-996-8100 | |
Dr. Rolando Sousa, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 20 Prospect Ave, Suite 905, Hackensack, NJ 07601 Phone: 973-222-4653 Fax: 646-304-3194 |